Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Erasca, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 146
- +15 vs. Q3 2024
- Shares held
- 230.9M
- −1.15M (−0.5%) vs. Q3 2024
- Total value
- $579.5M
- −$53.9M (−8.5%) vs. Q3 2024
- New holders
- 27
- 52 more added
- Sold out
- 12
- 39 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $5.13B |
| Q1 2026 | 225 | $4.39B |
| Q4 2025 | 154 | $815.7M |
| Q3 2025 | 141 | $468.5M |
| Q2 2025 | 142 | $277.1M |
| Q1 2025 | 154 | $307.3M |
| Q4 2024 | 146 | $579.5M |
| Q3 2024 | 132 | $633.4M |
| Q2 2024 | 126 | $480.6M |
| Q1 2024 | 108 | $149.7M |
| Q4 2023 | 119 | $147.5M |
| Q3 2023 | 109 | $140.4M |
| Q2 2023 | 112 | $205.2M |
| Q1 2023 | 118 | $234.9M |
| Q4 2022 | 107 | $343.9M |
| Q3 2022 | 88 | $627.9M |
| Q2 2022 | 89 | $428.3M |
| Q1 2022 | 82 | $626.6M |
| Q4 2021 | 63 | $988.0M |
| Q3 2021 | 55 | $919.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 377,764 | $948.2K | 0.00% | +33,834+9.8% | Added |
| UBS Asset Management Americas Inc | 444,769 | $1.12M | 0.00% | +80,684+22.2% | Added |
| Wellington Management Group LLP | 465,672 | $1.17M | 0.00% | +465,672 | New |
| Bank of New York Mellon Corp | 544,819 | $1.37M | 0.00% | +35,268+6.9% | Added |
| Nuveen Asset Management, LLC | 555,704 | $1.39M | 0.00% | +72,121+14.9% | Added |
| Two Sigma Advisers, LP | 594,600 | $1.49M | 0.00% | −198,600−25.0% | Reduced |
| Tang Capital Management LLC | 602,915 | $1.51M | 0.10% | +100,000+19.9% | Added |
| Morgan Stanley | 754,738 | $1.89M | 0.00% | −118,403−13.6% | Reduced |
| Atom Investors LP | 775,417 | $1.95M | 0.24% | +775,417 | New |
| EDBI Pte Ltd | 888,888 | $2.23M | 2.36% | 00.0% | Unchanged |
| Prosight Management, LP | 947,110 | $2.38M | 0.67% | −1,036,900−52.3% | Reduced |
| Two Sigma Investments, LP | 958,245 | $2.41M | 0.01% | −386,668−28.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $2.51M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,133,000 | $2.84M | 0.00% | −158,000−12.2% | Reduced |
| Sio Capital Management, LLC | 1,356,186 | $3.40M | 0.96% | −863,000−38.9% | Reduced |
| JPMorgan Chase & Co | 1,474,585 | $3.70M | 0.00% | −549,929−27.2% | Reduced |
| Northern Trust Corp | 1,717,109 | $4.31M | 0.00% | +179,160+11.6% | Added |
| Charles Schwab Investment Management Inc | 1,762,696 | $4.42M | 0.00% | +39,066+2.3% | Added |
| Sofinnova Investments, Inc. | 1,795,880 | $4.51M | 0.33% | −46,788−2.5% | Reduced |
| Bank of America Corp | 1,945,773 | $4.88M | 0.00% | −2,274,898−53.9% | Reduced |
| Marshall Wace, LLP | 2,027,027 | $5.09M | 0.01% | −1,000,700−33.1% | Reduced |
| Dimensional Fund Advisors LP | 2,111,986 | $5.30M | 0.00% | +903,687+74.8% | Added |
| Soleus Capital Management, L.P. | 2,162,162 | $5.43M | 0.41% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 2,499,431 | $6.27M | 0.98% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,801,630 | $7.03M | 0.00% | −428,726−13.3% | Reduced |
| AH Capital Management, L.L.C. | 2,862,500 | $7.18M | 0.96% | 00.0% | Unchanged |
| Woodline Partners LP | 4,147,275 | $10.4M | 0.07% | +8,426+0.2% | Added |
| Millennium Management LLC | 4,177,900 | $10.5M | 0.01% | +1,767,350+73.3% | Added |
| Citadel Advisors LLC | 4,288,369 | $10.8M | 0.01% | −27,304−0.6% | Reduced |
| PFM Health Sciences, LP | 4,390,427 | $11.0M | 0.84% | −486,484−10.0% | Reduced |
| Geode Capital Management, LLC | 4,569,819 | $11.5M | 0.00% | +67,121+1.5% | Added |
| Octagon Capital Advisors LP | 5,136,795 | $12.9M | 2.20% | +5,136,795 | New |
| 5AM Venture Management, LLC | 5,405,404 | $13.6M | 3.24% | 00.0% | Unchanged |
| State Street Corp | 6,609,481 | $16.6M | 0.00% | +581,861+9.7% | Added |
| Vivo Capital, LLC | 6,756,756 | $17.0M | 1.90% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 7,543,901 | $18.9M | 4.23% | +597,413+8.6% | Added |
| Siren, L.L.C. | 8,857,179 | $22.2M | 0.98% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 10,752,354 | $27.0M | 0.94% | +84,213+0.8% | Added |
| ARCH Venture Management, LLC | 11,055,554 | $27.7M | 12.05% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 12,315,004 | $30.9M | 1.15% | −1,453,035−10.6% | Reduced |
| Logos Global Management LP | 12,500,000 | $31.4M | 3.67% | +1,600,000+14.7% | Added |
| Vanguard Group Inc | 12,673,900 | $31.8M | 0.00% | −614,840−4.6% | Reduced |
| BlackRock, Inc. | 15,761,364 | $39.6M | 0.00% | +404,684+2.6% | Added |
| VR Adviser, LLC | 16,216,216 | $40.7M | 2.79% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 16,710,347 | $41.9M | 0.03% | −120,509−0.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 19,391,687 | $48.7M | 2.02% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −230,854−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −169,460−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −75,647−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −63,599−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −60,848−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −47,830−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −46,923−100.0% | Sold out |
| Brown Wealth Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,685−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Edmonds Duncan Registered Investment Advisors, LLC | – | – | – | – | Not filed |